Aptose Biosciences Inc. (APTO)
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Address
66 WELLINGTON STREET WEST, SUITE 5300
TORONTO, A6 M5K 1E6
Founded
1986
Number of Employees
35
Website
http://www.aptose.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)